EUROIMMUN has introduced two ELISAs for the detection of IgM and IgG antibodies against Oropouche virus. Oropouche virus is the causative agent of Oropouche fever, an emerging disease which manifests with dengue-like symptoms such as sudden onset of high fever, myalgia, rash, joint pain and vomiting. The virus circulates in Central and South America and […]
respons®940 is an automated random access clinical chemistry analyzer and offers a constant throughput of minimum 400 tests/h, independently whether a mono- or two component reagent is used. Including the optionally available ISE module with additional 240 test/h the total throughout increases to 640 tests/h.
Biotech Fluidics has published a practical review paper that demonstrates how its MarvelX™ and MarvelXACT™ high pressure fluidic connections enable users to achieve reliable, repeatable, and consistent UHPLC performance. In this paper, fluidic experts explore the connection challenges facing users of modern UHPLC instruments.
Beckman Coulter Life Sciences has introduced a new Light Array Module (LAM) for the BioLector XT Microbioreactor which is set to advance research with a wide range of phototrophic organisms.
FUJIFILM Irvine Scientific, a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, has more than doubled their R&D facility’s footprint with the recent completion of its Armstrong Cell Culture Center of Excellence.
https://clinlabint.com/wp-content/uploads/sites/2/2022/08/fujifilm2-scaled-e1663868131614.jpg6751200panglobalhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngpanglobal2022-08-04 08:41:352024-08-21 13:59:28FUJIFILM Irvine Scientific opens new Armstrong R&D Cell Culture Center of Excellence in California
German independent research institute BioMed X has started a new research project ‘Advanced Biomarker Detection for Pharma-cological Monitoring in the Brain’ (BDB) in collaboration with Boehringer Ingelheim. The objective of the research group ‘BDB’ is to develop a continuous monitoring biosensor for direct detection of small molecule biomarkers in rodent brain tissue to support the […]
https://clinlabint.com/wp-content/uploads/sites/2/2022/03/bioMed_Xv2.jpg6671000panglobalhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngpanglobal2022-03-23 09:54:172022-03-23 09:54:17BioMed X Institute and Boehringer Ingelheim start new research project in brain sensor development
CytoSMART Technologies has launched their new brightfield live-cell imaging system – the CytoSMART Lux3 BR. The small brightfield microscope is equipped with a high-quality 6.4 MP CMOS camera.
Like other CytoSMART microscopes, this new live-cell imager is designed to work inside a standard cell culture incubator without disturbing temperature, airflow, and optimum culture conditions for the cells. This allows researchers to perform long-term live-cell imaging experiments, ensuring optimal cell growth and health.
Very detailed brightfield images can be captured using the new device. With 2072 pixel resolution in both x- and y-axes, combined with 1.45 mm field of view, the microscope provides a resolution of 0.7 µm/pixel. Even at the commonly required image resolution of 300 dpi for printed publications, these images can fill the entire page without compromising image quality.
Jan-Willem van Bree, CTO at CytoSMART Technologies, commented: “We are very excited to expand our label-free microscopy solutions for live-cell studies. For cell biologists who want to incorporate live-cell imaging into their workflow, the resolution of live-cell imaging microscopes may be too low for accurately quantifying complex read-outs, such as cell tracking or differentiation processes. This causes inaccurate and variable results that compromise the research output. Unlike the high-end microscopes with incubation box, the Lux3 BR ensures that cultures are not exposed to temperature, humidity, or CO2 fluctuations that can stress the cells, as the device easily fits in every CO2-incubator. It is a powerful addition to each research lab.”
The CytoSMART Lux3 BR setup can be easily expanded to two or even four devices that can be operated and controlled individually via a single laptop. Since both Lux3 BR Duo Kit and Multi Lux3 BR devices can be placed directly next to each other in the same incubator, it allows for systematic comparison of control and treated samples, as all monitored cell cultures are maintained in an identical culture environment.
The main features and benefits of the CytoSMART Lux3 BR include:
High-quality images and time-lapse movies to investigate the development of cellular processes
Incubator- and laboratory-friendly due to its compact size and open design
Remote data access via the CytoSMART Cloud with a smartphone, tablet, or laptop outside the lab
Flexibility to expand a single live-cell imaging system to Duo and Multi Kits
ZTA Biotech, a Budapest-based biotech startup has announced the breakthrough development of a COVID-19 antibody (IgG) test using the ELISA protocol. This new detection method represents a great step forward in determining if patients have had COVID-19 and if they might still have immunity to the disease. Early results have proven 100% in specificity after testing 280 samples, and 100% sensitivity by testing 260 samples of recovered and symptomatic patients.
Two types of photon detectors are used to amplify and then convert lightinto electronic signals in flow cytometry. The traditional detector is the photomultiplier tube (PMT). Avalanche Photodiodes (APD) are another type of photon detector and are used in the DxFLEX flow cytometer.
The best outcomes in cancer treatment can be achieved with early diagnosis. Prostate-specific antigen (PSA) is unique in that it is the only tissue-specific biomarker that can aid in the early diagnosis…
https://clinlabint.com/wp-content/uploads/sites/2/2017/08/Critical-Thinking-for-Early-Diagnosis-of-Prostate-Cancer.png5066633wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2017-08-17 08:54:042021-01-14 12:50:31(OLD) Critical Thinking for Early Diagnosis of Prostate Cancer
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.